简体中文 | 繁體中文 | English

G/GE Healthcare2

A Revolution in Minimally Invasive Imaging: GE Healthcare Unveils New Category of Interventional Imaging Systems

2011-11-29 16:22
  • zh_cn
  • zh_hant
  • en

First-of-its-kind Discovery IGS 7301 combines benefits of floor- and ceiling-mounted imaging systems for predictable and precise positioning capabilities, enabling access to patients "like never before"

CHICAGO--(BUSINESS WIRE)--At RSNA 2011, GE Healthcare (NYSE: GE) will reveal the Discovery IGS 730, the first Interventional X-ray system designed to capture the advantages of both floor- and ceiling-mounted systems. With laser-guided motion technology on a motorized mobile gantry for predictable and precise trajectories, Wide Bore 3D for ease in 3D acquisitions, and more than 20 advanced applications available, the Discovery IGS 730 is positioned for a new era of interventional procedures. The significance of this innovation to interventional imaging has been compared to that of the invention of flat panel technology.

"Our goal was to pioneer a solution that eliminates the historical trade-offs our customers had to make when selecting from the interventional imaging systems. In general, the trade-off between ceiling- and floor-mounted systems means compromising patient access for room airflow and sterility, while the choice between fixed units and mobile C-arms means compromising image quality for mobility. Now interventionalists and surgeons who perform complex minimally invasive procedures have an entirely new category of imaging system that eliminates the need to compromise: Discovery. At GE Healthcare, we believe the Discovery IGS 730 has the potential to revolutionize the field of interventional imaging," said Hooman Hakami, president and CEO of GE Healthcare Interventional Systems.

The Discovery IGS 730 is a revolution in imaging. It is neither floor- nor ceiling-mounted, but enables full patient access without the need to suspend the system above the patient. It has the mobility of a C-arm with the power and image quality of a fixed system. This laser-guided, motorized mobile gantry creates an interventional environment without boundaries. It allows complete access to the patient and unlimited parking capability, while creating sterility for a flexible and secure OR environment. The unique gantry comes with a new wide bore design, which allows for steep angles, ease in 3D acquisition, especially for large patients.

The Discovery IGS 730 C-arm is mounted on an Advanced Guided Vehicle (AGV), a motorized and fully mobile system. Based on laser guidance, the AGV can move freely from imaging position to parking or back-out positions, using predefined trajectories to provide total patient access. The Discovery IGS 730 features One-Touch-Back-Out, enabling fast and easy gantry movement away from the patient. The motion is predictable, precise and easy to use, allowing fine control and positioning at any moment in the procedure. Parking locations and back-out distances are customizable for different room configurations.

"My first impression was that this system will allow us to have levels of access to patients in ways we have never had before. This particular unit removes the limitations of both ceiling- and floor-mounted systems without losing any of the advantages," said Dr. Hal Folander, chairman of the Radiology Department and Section Chief of Interventional Radiology at St. Luke's Hospital and Health Network in Pennsylvania, who has participated in clinical simulations on phantoms using the Discovery IGS 730. "Having been involved in research and development of this type of product for 25 years, I would say this is, probably, one of the most revolutionary interventional projects that I've seen. The innovation will be equivalent to or greater than the invention of flat panel technology for interventional procedures."

In addition to being mobile, Discovery IGS 730 comes equipped with more than 20 advanced applications. One example is the new Wide Bore 3D application for ease in 3D acquisitions and the ability to allow off-centered 3D acquisitions to cover anatomies such as the borders of the liver during liver oncology procedures or the skin line during image-guided needle procedures.

"With Discovery IGS 730, doctors will be able to rediscover space and movement while accessing all the advanced imaging capabilities of GE premium interventional systems," said Chantal Le Chat, general manager of GE Healthcare Interventional Radiology.

GE Healthcare at RSNA 2011

Each year in Chicago, the conference of the Radiological Society of North America (RSNA) provides a forum for showcasing the latest innovations in medical imaging. If you are attending the conference, please visit GE Healthcare at booth 3335 in McCormick Place south hall. Throughout the week of the event, GE Healthcare will distribute news and information using these digital platforms:

NOTE TO EDITORS

Photos, videos, and additional materials will be available online after 1:00 pm CST here: http://newsroom.gehealthcare.com/discovery.

ABOUT GE HEALTHCARE

GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care. Our broad expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, drug discovery, biopharmaceutical manufacturing technologies, performance improvement and performance solutions services help our customers to deliver better care to more people around the world at a lower cost. In addition, we partner with healthcare leaders, striving to leverage the global policy change necessary to implement a successful shift to sustainable healthcare systems.

Our "healthymagination" vision for the future invites the world to join us on our journey as we continuously develop innovations focused on reducing costs, increasing access and improving quality around the world. Headquartered in the United Kingdom, GE Healthcare is a unit of General Electric Company (NYSE: GE). Worldwide, GE Healthcare employees are committed to serving healthcare professionals and their patients in more than 100 countries. For more information about GE Healthcare, visit our website at www.gehealthcare.com.

For our latest news, please visit http://newsroom.gehealthcare.com.

1 Discovery IGS 730 is 510(k) pending at FDA, and not available for sale in the United States.

Contacts

GE Healthcare
Holly Langdon, +1-414-429-6998
holly.langdon@ge.com